Exposure to the World Trade Center Disaster, Health, and Health‐Related Quality of Life Nearly 20 Years After 9/11
American Journal of Industrial Medicine · 2025
DOI: 10.1002/ajim.23706 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Industrial Medicine, 2025. Verfasst von Julia S Sisti und 5 weiteren Autor:innen. Beteiligte Einrichtung: New York City Department of Health and Mental Hygiene, World Trade Center Health Registry, Long Island City, New York, USA. Hauptthemen laut MEDLINE: September 11 Terrorist Attacks, Quality of Life, Stress Disorders, Post-Traumatic, Health Status. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIOSH CDC HHS, The study was supported by the National Institute for Occupational Safety and Health (U50OH009739)., National Institute for Occupational Safety and Health.
Abstract (Originalsprache)
Background
Exposure to the terrorist attacks on the World Trade Center (WTC) on September 11, 2001, has been associated with several chronic physical and mental health conditions. We assessed the burden, nearly 20 years after the attacks, of several 9/11‐related health conditions and indicators of poor health‐related quality of life (HRQOL) among individuals exposed to the WTC disaster.
Methods
Among individuals enrolled in the longitudinal WTC Health Registry in 2020–2021 ( N = 26,964), we estimated post‐9/11 prevalence of: self‐reported diagnosed physical health conditions known to be associated with WTC exposure; probable posttraumatic stress disorder (PTSD) and depression; and poor HRQOL indicators. We also compared lifetime prevalence of selected conditions and poor‐HRQOL indicators among WTC‐exposed rescue and recovery workers and community members, separately, to New York State general population estimates, using multivariable‐adjusted logistic regression.
Results
Prevalence of post‐9/11 physical health conditions ranged from 10.5% (chronic obstructive pulmonary disease, COPD) to 26.3% (gastroesophageal reflux disease). Prevalence of probable post‐9/11 PTSD and depression were 9.6% and 12.7%, respectively. Lifetime prevalence of physician‐diagnosed asthma, COPD, and depression were higher among WTC‐exposed individuals compared to the general population. Indicators of poor HRQOL were higher among WTC Registry enrollees relative to the general population, and among enrollees with any physical or probable mental health conditions compared to enrollees without any conditions.
Conclusions
Nearly 20 years after 9/11, WTC‐exposed populations experience a high burden of health conditions that affect their wellbeing, highlighting the need for continued monitoring of this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- New York City Department of Health and Mental Hygiene, World Trade Center Health Registry, Long Island City, New York, USA.
Förderung
- NIOSH CDC HHS
- The study was supported by the National Institute for Occupational Safety and Health (U50OH009739).
- National Institute for Occupational Safety and Health
Zitieren
APA
Sisti, J. S., Dhanya, A., Alper, H. E., Millet, N., Ahmadi, A., & Brackbill, R. M. (2025). Exposure to the World Trade Center Disaster, Health, and Health‐Related Quality of Life Nearly 20 Years After 9/11. American Journal of Industrial Medicine. https://doi.org/10.1002/ajim.23706
Vancouver
Sisti JS, Dhanya A, Alper HE, Millet N, Ahmadi A, Brackbill RM. Exposure to the World Trade Center Disaster, Health, and Health‐Related Quality of Life Nearly 20 Years After 9/11. American Journal of Industrial Medicine. 2025. doi:10.1002/ajim.23706
BibTeX
@article{Sisti2025,
author = {Sisti, Julia S and Dhanya, Ananya and Alper, Howard E and Millet, Nicholas and Ahmadi, Ayda and Brackbill, Robert M},
title = {Exposure to the World Trade Center Disaster, Health, and Health‐Related Quality of Life Nearly 20 Years After 9/11},
journal = {American Journal of Industrial Medicine},
year = {2025},
doi = {10.1002/ajim.23706}
}
EUVIMED